Stubberud, Anker
Tronvik, Erling
Matharu, Manjit
Funding for this research was provided by:
University College London
Article History
Accepted: 22 October 2020
First Online: 11 November 2020
Compliance with Ethical Standards
:
: Dr. Matharu reports grants and other funding from Abbott, Medtronic, Autonomic technologies, Allergan, TEVA, Novartis, Eli Lilly, and electroCore outside the submitted work. In addition, Dr. Matharu has issued a patent for his system and method for diagnosing and treating headaches. Dr. Stubberud is a co-founder and shareholder of Nordic Brain Tech, a company developing a non-pharmacological biofeedback treatment for migraines and he holds a pending patent application relating to the company’s product. Dr. Tronvik reports funds from a Nordic BrainTech shareholder, a Palion Medical shareholder, and personal fees from Advisory Boards TEVA, Allergan, Novartis, and Eli Lilly. Funds are also reported from Speaker honoraria TEVA, Novartis, and Eli Lilly outside the submitted work.
: All reported studies/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines).